BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28177941)

  • 1. Clinically Significant Bradycardia From Tizanidine.
    Masood U; Kahlon A; Mousa O
    Am J Ther; 2018; 25(3):e385-e386. PubMed ID: 28177941
    [No Abstract]   [Full Text] [Related]  

  • 2. Symptomatic bradycardia probably due to tizanidine hydrochloride in a chronic hemodialysis patient.
    Kitabata Y; Orita H; Kamimura M; Shiizaki K; Narukawa N; Abe T; Kobata H; Akizawa T
    Ther Apher Dial; 2005 Feb; 9(1):74-7. PubMed ID: 15828911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of sirdalud in the drug therapy of pain in the spine].
    Iakhno NN; Damulin IV; Chernenko OA; Ianakaeva TA; Kondrat'eva ON; Kur'ianova PT
    Ter Arkh; 1994; 66(10):10-2. PubMed ID: 7863433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of Medication Reconciliation: Tizanidine-Induced Hepatitis.
    Gill D; Allam F; Boyle J
    Am J Ther; 2017; 24(5):e623-e624. PubMed ID: 28323749
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose tizanidine abuse.
    Zullino DF; Eskenasy AC; Beeson J
    Psychopharmacol Bull; 2003; 37(3):5-6. PubMed ID: 15270008
    [No Abstract]   [Full Text] [Related]  

  • 6. Tizanidine for spasticity.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):62-3. PubMed ID: 9217694
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
    Nance PW; Bugaresti J; Shellenberger K; Sheremata W; Martinez-Arizala A
    Neurology; 1994 Nov; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tizanidine withdrawal symptoms in stress cardiomyopathy].
    Mörkl S; Bengesser SA; Schöggl H; Bayer D; Kapfhammer HP
    Fortschr Neurol Psychiatr; 2015 Mar; 83(3):170-3. PubMed ID: 25794323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxysmal Hypertension Associated With Presyncope.
    Luther JM; Dominiczak AF; Jennings GLR; VanDevender FK; Carey RM; Peixoto AJ; Chung CP; Oates JA
    Hypertension; 2019 Oct; 74(4):718-725. PubMed ID: 31476903
    [No Abstract]   [Full Text] [Related]  

  • 11. An approach to switching patients from baclofen to tizanidine.
    Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a simple spasticity quantification method: effects of tizanidine on spasticity in patients with sequelae of cerebrovascular disease.
    Ogawa N; Asanuma M; Hirata H; Ota Z; Yamawaki Y; Yamamoto M
    J Int Med Res; 1992 Feb; 20(1):78-86. PubMed ID: 1568522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary of combined clinical analysis of controlled clinical trials with tizanidine.
    Wallace JD
    Neurology; 1994 Nov; 44(11 Suppl 9):S60-8; discussion S68-9. PubMed ID: 7970013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain.
    Ketenci A; Ozcan E; Karamursel S
    Int J Clin Pract; 2005 Jul; 59(7):764-70. PubMed ID: 15963201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial.
    Childers MK; Borenstein D; Brown RL; Gershon S; Hale ME; Petri M; Wan GJ; Laudadio C; Harrison DD
    Curr Med Res Opin; 2005 Sep; 21(9):1485-93. PubMed ID: 16197668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative profile of tizanidine in the management of spasticity.
    Lataste X; Emre M; Davis C; Groves L
    Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new skeletal muscle relaxant (DS 103-282) compared to diazepam in the treatment of muscle spasm of local origin.
    Hennies OL
    J Int Med Res; 1981; 9(1):62-8. PubMed ID: 6451461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tizanidine (DS 103-282) in the treatment of acute paravertebral muscle spasm: a controlled trial comparing tizanidine and diazepam.
    Fryda-Kaurimsky Z; Müller-Fassbender H
    J Int Med Res; 1981; 9(6):501-5. PubMed ID: 6459256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative effciency of bakloferon and tolperizon central muscle relaxants in complex therapy of back pain].
    Vorob'eva OV; Kozlova IM
    Voen Med Zh; 2006 Sep; 327(9):52-5. PubMed ID: 17180860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.